Key Takeaways Nutrition strategies can complement GLP-1 medications by improving adherence, reducing hunger, and supporting more sustainable weight loss outcomes
Ask whether any medications approved for hypoactive sexual desire disorder might be appropriate as an adjunct to your current treatment
Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women
They observed, following L-carnitine supplementation (3 g/day for 3 weeks) in healthy untrained men, a reduction in circulating CK and DOMS compared to placebo
Min & Kim, Diabetes Metab J, 2022 The Next Generation of Metabolic Medicine The efficacy and safety of Tirzepatide are supported by the extensive SURPASS and SURMOUNT clinical trial programs, heralding a new era in weight management
The results have prompted a clinical trial to determine whether the association reflects a true protective effect